伦敦初创公司 Limbic 近日宣布完成了一笔价值 1400 万美元的 A 轮融资，引领这场投资风潮的是知名风投 Khosla Ventures，同时参与投资的还有 Gaingels 和 Illusian。这家专注于人工智能在心理健康领域的应用公司，自 2018 年成立以来，已经取得了显著的成就。
Limbic 的核心产品是一款人工智能心理治疗聊天机器人，以及一款基于 AI 的临床转诊软件。目前，这款聊天机器人在英国国家医疗服务体系（NHS）中广泛应用，服务于 33% 的 NHS 谈话治疗项目，惠及了约 26 万名患者。这一数据充分展示了 Limbic 的技术在实际应用中的广泛性和影响力。
此轮融资的注入，将加速 Limbic 扩张的步伐，尤其是将其创新解决方案推向美国市场。Limbic 的人工智能技术有望在美国心理健康领域产生深远影响，为患者提供更便捷、个性化的心理支持服务，同时减轻传统医疗系统的压力。随着全球对心理健康问题的关注度日益提高，Limbic 的发展势头不容小觑，其 AI 解决方案可能会成为行业新标准的一部分。
英语如下：
News Title: “AI Mental Health Pioneer Limbic Secures $14M Series A Funding, Sets Sights on US Expansion”
Keywords: AI therapy assistant, Limbic company, $14 million funding
News Content: London-based startup Limbic recently announced a $14 million Series A funding round led by prominent venture capital firm Khosla Ventures, with participation from Gaingels and Illusian. Since its founding in 2018, the company, which specializes in AI applications for mental health, has made significant strides.
At the heart of Limbic’s offerings is an AI-powered mental health chatbot and an AI-driven clinical referral software. The chatbot is currently widely utilized within the UK’s National Health Service (NHS), supporting 33% of its talking therapy programs and assisting approximately 260,000 patients, demonstrating the broad reach and impact of its technology.
This fresh injection of capital will hasten Limbic’s expansion, particularly as it pushes its innovative solutions into the US market. The company’s AI technology is poised to make a substantial difference in the American mental health sector, offering more accessible and personalized support to patients while alleviating pressure on traditional healthcare systems. With growing global attention on mental health issues, Limbic’s growth prospects are significant, and its AI solutions could become a part of the new industry standard.
【来源】https://sifted.eu/articles/limbic-series-a-14m-ai-chatbot-news
Views: 4